Application of validated severity scores for pneumonia caused by SARS-CoV-2

Welte, 2012, Clinical and economic burden of community-acquired pneumonia among adults in Europe, Thorax., 67, 71, 10.1136/thx.2009.129502 Ministerio de Sanidad. Gobierno de España. Información científica-técnica, enfermedad por coronavirus, COVID-19. Instituto de Salud Carlos III. Dirección General de Salud Pública, Calidad e Innovación. Centro de Coordinación de Alertas y Emergencias Sanitarias. Actualización; 15 de enero 2021. Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA., 323, 1239, 10.1001/jama.2020.2648 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med., 382, 1708, 10.1056/NEJMoa2002032 Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med., 180, 934, 10.1001/jamainternmed.2020.0994 Emanuel, 2020, Fair allocation of scarce medical resources in the time of Covid-19, N Engl J Med., 382, 2049, 10.1056/NEJMsb2005114 Steinberg, 2020, Calculated decisions: COVID-19 calculators during extreme resource-limited situations, Emerg Med Pract., 22, CD1 Loke, 2010, Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis, Thorax., 65, 884, 10.1136/thx.2009.134072 Yandiola, 2009, Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia, Chest., 135, 1572, 10.1378/chest.08-2179 Beigel, 2020, Remdesivir for the treatment of Covid-19 – Final Report, N Engl J Med., 383, 1813, 10.1056/NEJMoa2007764 Horby, 2020, Dexamethasone in hospitalized patients with COVID-19 - Preliminary report, N Engl J Med. Moreno-Pérez, 2020, Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up. A retrospective cohort study, J Autoimmun., 114, 10.1016/j.jaut.2020.102523 Menéndez, 2010, Neumonía adquirida en la comunidad Nueva normati va de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Arch Bronconeumol., 46, 543, 10.1016/j.arbres.2010.06.014 Mandell, 2007, Infectious Diseases Society of America/American Thoracic Society Consensus guidelines on the management of community-acquired pneumonia in adults, Clin Infect Dis., 1, S27, 10.1086/511159 Metlay, 2019, Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, Am J Respir Crit Care Med., 200, e45, 10.1164/rccm.201908-1581ST Fine, 1997, A prediction rule to identify low-risk patients with community-acquired pneumonia, N Engl J Med., 336, 243, 10.1056/NEJM199701233360402 Lim, 2003, Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study, Thorax., 58, 10.1136/thorax.58.5.377 Muller, 2019, Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza, PLoS One., 5, e9563, 10.1371/journal.pone.0009563 Kim, 2019, Pneumonia severity index in viral community acquired pneumonia in adults, PLoS One., 14 Riquelme, 2011, Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia, Int J Tuberc Lung Dis., 15, 542, 10.5588/ijtld.10.0539 Pereira, 2012, Severity assessment tools in ICU patients with 2009 influenza A (H1N1) pneumonia, Clin Microbiol Infect., 18, 1040, 10.1111/j.1469-0691.2011.03736.x Guo, 2019, Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score, Front Microbiol., 10, 2752, 10.3389/fmicb.2019.02752 Liang, 2020, Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19, JAMA Intern Med., 180, 1, 10.1001/jamainternmed.2020.2033 Satici, 2020, Performance of Pneumonia Severity Index and CURB-65 in Predicting 30-day mortality in patients with COVID-19, Int J Infect Dis., 98, 84, 10.1016/j.ijid.2020.06.038 Fan, 2020, Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study, Eur Respir J., 56, 10.1183/13993003.02113-2020 Mandrekar, 2019, Receiver operating characteristic curve in diagnostic test assess-ment, J Thorac Oncol., 5, 1315, 10.1097/JTO.0b013e3181ec173d Gattioni, 2020, COVID-19pneumonia: Different respiratory treatments for different phenotypes?, Inten-sive Care Med., 46, 1099, 10.1007/s00134-020-06033-2 Rawson, 2020, Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing, Clin Infect Dis., 71, 2459 Hughes, 2020, Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting, Clin Microbiol Infect., 26, 1395, 10.1016/j.cmi.2020.06.025 Lansbury, 2020, Co-infection in people with COVID-19: a systematic review and meta-analysis, J Infect., 81, 266, 10.1016/j.jinf.2020.05.046